Neuralink Implants Computer Chip in First Human Test Subject
A computer chip developed by Neuralink has been successfully implanted in a human test subject, according to Elon Musk, the co-founder of the company. This marks a significant milestone in the field of Brain-Computer Interface (BCI) research.
Promising Results and the Vision for Telepathy
Musk announced on Twitter that the first human recipient of the implant is recovering well, and initial results show promising neuron spike detection. The objective of Neuralink’s BCI research is to decode intended movement signals from brain activity to control external devices. Musk also shared his vision for the company’s first product: Telepathy. He explained that it would enable control of devices just by thinking, benefiting individuals who have lost the use of their limbs.
Human Trials and Volunteer Requirements
In September, Neuralink received approval from the Food and Drug Administration to begin human trials. The company then put out a call for volunteers for its PRIME study, specifically targeting individuals with quadriplegia or amyotrophic lateral sclerosis (ALS). Participants must be at least 22 years old and have a reliable caregiver. The study involves nine visits over 18 months, as well as ongoing sessions after completion.
The Technology Behind Neuralink
The study tests various components, including the N1 implant, which has 1,024 electrodes and is cosmetically invisible. These electrodes record and transmit neural activity to a mobile app, allowing patients to control a computer with their thoughts. Additionally, a robot is used to surgically place the implant in the brain region responsible for movement intention.
The Controversy Surrounding Neuralink
Neuralink’s approach to BCI technology has faced criticism from animal rights groups. The Physicians Committee for Responsible Medicine claims that Neuralink’s surgical implants have severe medical complications and violate the Animal Welfare Act. The group has called for an end to animal experiments and the focus on noninvasive brain-machine interfaces.
The Significance of Neuralink’s Advancement
Neuralink’s progress in human testing highlights the growing interest and demand for neurotechnology. Other companies, such as Motif Neurotech, are also developing innovative approaches to brain interfaces. Motif Neurotech CEO Jacob Robinson sees Neuralink’s advancements as validation for the field of neurotechnology.
Hot Take: Neuralink Pioneers Brain-Computer Interface Research with Successful Human Implant
Neuralink’s successful implantation of its computer chip in a human test subject represents a significant breakthrough in Brain-Computer Interface (BCI) research. By decoding intended movement signals from brain activity, Neuralink aims to enable individuals to control external devices simply by thinking. While the company has faced controversy regarding its surgical approach and animal testing, its progress signals a growing interest in neurotechnology. As more companies like Neuralink and Motif Neurotech develop innovative brain interfaces, the possibilities for enhancing human capabilities through technology continue to expand.
By
By
By
By